World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
53
Citations
11928
World Ranking
3960
National Ranking
7

Dimitrios Paraskevis publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Dimitrios Paraskevis sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 335 publications — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Dimitrios Paraskevis D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Dimitrios Paraskevis sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 53 D-Index — 20th percentile

20% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Dimitrios Paraskevis is affiliated with the National and Kapodistrian University of Athens in Greece. Their research primarily focuses on medicine, with a particular emphasis on infectious diseases, epidemiology, molecular biology, virology, and modeling and simulation.

The scientist's work covers several major topics, which include:

  • SARS-CoV-2 and COVID-19 research
  • HIV/AIDS research and interventions
  • COVID-19 clinical research studies
  • HIV, drug use, sexual risk
  • COVID-19 epidemiological studies
  • HIV research and treatment
  • SARS-CoV-2 detection and testing

Dimitrios Paraskevis has frequently published in several venues, with the most publications appearing in:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Viruses
  • The Science of The Total Environment
  • Life
  • Infection Genetics and Evolution

Their recent papers demonstrate a continued interest in viral genetics and epidemiology. Notable works include:

  • "Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event," published in 2020 in Infection Genetics and Evolution
  • "Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications," published in 2021 in Journal of Biomedical Science
  • "Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis," published in 2022 in Trends in Molecular Medicine
  • "SARS-CoV-2 wastewater surveillance data can predict hospitalizations and ICU admissions," published in 2021 in The Science of The Total Environment
  • "Phylogenetic Analysis of SARS-CoV-2 Data Is Difficult," published in 2020 in Molecular Biology and Evolution

Collaboration is a significant aspect of their research. Frequent co-authors include:

  • Sotirios Tsiodras
  • Evangelia Georgia Kostaki
  • Vana Sypsa
  • Angelos Hatzakis
  • Gkikas Magiorkinis

The scope of Dimitrios Paraskevis's research spans multiple related subfields, ranging from infectious diseases and epidemiology to molecular and virology studies. This multidisciplinary approach supports investigations into the molecular mechanisms of viruses as well as broader public health and clinical implications of infectious diseases.

Best Publications

  • Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event.

    Dimitrios Paraskevis;Evangelia Georgia Kostaki;Gkikas Magiorkinis;George Panayiotakopoulos

  • An automated genotyping system for analysis of HIV-1 and other microbial sequences

    Tulio De Oliveira;Koen Deforche;Sharon Cassol;Mika Salminen

  • Prevalence of Drug-Resistant HIV-1 Variants in Untreated Individuals in Europe: Implications for Clinical Management

    Annemarie M. J. Wensing;David A. van de Vijver;Gioacchino Angarano;Birgitta Åsjö

  • A global scientific strategy to cure hepatitis B

    Peter A Revill;Francis V Chisari;Joan M Block;Maura Dandri

  • Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis

    Unknown

  • Transmission of Drug-Resistant HIV-1 Is Stabilizing in Europe

    Jurgen Vercauteren;Annemarie M. J. Wensing;David A. M. C. van de Vijver;Jan Albert

  • Impact of Hepatitis B Virus Infection on the Progression of AIDS and Mortality in HIV-Infected Individuals: A Cohort Study and Meta-Analysis

    Georgios K Nikolopoulos;Dimitrios Paraskevis;Eleni Hatzitheodorou;Zissis Moschidis

  • The Global Spread of Hepatitis C Virus 1a and 1b: A Phylodynamic and Phylogeographic Analysis

    Gkikas Magiorkinis;Emmanouil Magiorkinis;Dimitrios Paraskevis;Simon Y. W. Ho

  • Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications.

    Ioannis P Trougakos;Kimon Stamatelopoulos;Evangelos Terpos;Ourania E Tsitsilonis

  • SARS-CoV-2 wastewater surveillance data can predict hospitalizations and ICU admissions.

    Aikaterini Galani;Reza Aalizadeh;Marios Kostakis;Athina Markou

  • Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe

    L. Marije Hofstra;Nicolas Sauvageot;Jan Albert;Jan Albert;Ivailo Alexiev

  • European recommendations for the clinical use of HIV drug resistance testing: 2011 update

    Anne-Mieke Vandamme;Ricardo J Camacho;Francesca Ceccherini-Silberstein;Andreu de Luca;Andreu de Luca

  • HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics

    Ana B. Abecasis;Annemarie M.J. Wensing;Dimitris Paraskevis;Jurgen Vercauteren;Jurgen Vercauteren

  • Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach

    Dimitrios Paraskevis;Dimitrios Paraskevis;Oliver Pybus;Gkikas Magiorkinis;Angelos Hatzakis

  • Dating the origin and dispersal of hepatitis B virus infection in humans and primates.

    Dimitrios Paraskevis;Gkikas Magiorkinis;Gkikas Magiorkinis;Emmanouil Magiorkinis;Simon Y.W. Ho

  • Phylogenetic analysis of SARS-CoV-2 data is difficult.

    Benoit Morel;Pierre Barbera;Lucas Czech;Ben Bettisworth

  • HIV-1 outbreak among injecting drug users in Greece, 2011: a preliminary report.

    D Paraskevis;G Nikolopoulos;C Tsiara;D Paraskeva

  • Economic recession and emergence of an HIV-1 outbreak among drug injectors in Athens metropolitan area: A longitudinal study

    Dimitrios Paraskevis;Georgios Nikolopoulos;Georgios Nikolopoulos;Anastasios Fotiou;Chrissa Tsiara

  • The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes

    David A van de Vijver;Annemarie M J Wensing;Gioacchino Angarano;Birgitta Asjö

  • Impact of HIV-1 Subtype on CD4 Count at HIV Seroconversion, Rate of Decline, and Viral Load Set Point in European Seroconverter Cohorts

    Giota Touloumi;Nikos Pantazis;Deenan Pillay;Dimitrios Paraskevis

  • Molecular epidemiology of a hepatitis C virus outbreak in a haemodialysis unit. Multicentre Haemodialysis Cohort Study on Viral Hepatitis.

    A Katsoulidou;D Paraskevis;V Kalapothaki;D Arvanitis

Frequent Co-Authors

Angelos Hatzakis
Angelos Hatzakis National and Kapodistrian University of Athens
Samuel R. Friedman
Samuel R. Friedman National Development and Research Institutes
Anne-Mieke Vandamme
Anne-Mieke Vandamme Rega Institute for Medical Research
Charles A. Boucher
Charles A. Boucher Erasmus University Rotterdam
Mario Poljak
Mario Poljak University of Ljubljana
John A. Schneider
John A. Schneider University of Chicago
Anders Sönnerborg
Anders Sönnerborg Karolinska Institute
Claudia Balotta
Claudia Balotta University of Milan
Jan Albert
Jan Albert Karolinska Institute
Annemarie M. J. Wensing
Annemarie M. J. Wensing Utrecht University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA can open doors to various related healthcare careers, and pursuing online degrees offers flexibility for busy students. Many Immunology graduates consider expanding their expertise through nursing programs such as accelerated nursing programs, which allow for a faster transition into professional nursing roles.

For those seeking entry-level nursing positions, there are numerous lpn schools easy to get into that offer accessible programs with practical training. This pathway is ideal for Immunology students interested in hands-on patient care while building foundational healthcare skills.

Advanced clinical roles are also within reach through easiest np programs to get into. These programs prepare graduates for leadership roles in healthcare by expanding their clinical expertise and decision-making capabilities.

Moreover, there is growing demand for mental health specialists. Immunology students inclined towards this field might explore the best online psychiatric mental health nurse practitioner programs that combine specialized mental health training with strong clinical placement support.

Best Scientists Citing Dimitrios Paraskevis

Trending Scientists

Recently Published Articles